Produkty 110785-09-6

CAS 110785-09-6 występuje w naszej ofercie pod nazwami: Levonorgestrel Impurity 1（Levonorgestrel EP Impurity A）, rac-Levonorgestrel EP Impurity A , 8(14)-Dehydro Norgestrel. Oferty producentów: Hubei YoungXin, Chemat Brand, TRC, Biosynth. Dostępne opakowania: 10mg, 25mg, 50mg, 100mg, 200mg, on request, 0,5mg, 2,5mg.

Levonorgestrel Impurity 1（Levonorgestrel EP Impurity A）
Hubei YoungXin
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 5
Zobacz produkt
rac-Levonorgestrel EP Impurity A
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
8(14)-Dehydro Norgestrel
TRC, Biosynth
  • opakowanie: 0,5mg, 2,5mg, 1mg, 2mg
  • Warianty: 5
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(9R,10R,13R,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,9,10,11,12,15,16-decahydrocyclopenta[a]phenanthren-3-one (CAS 110785-09-6) to związek chemiczny o wzorze sumarycznym C21H26O2 i masie molowej 310.4 g/mol. Nazwa systematyczna IUPAC: (9R,10R,13R,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,9,10,11,12,15,16-decahydrocyclopenta[a]phenanthren-3-one. InChIKey: PIGNQOCLJHWTGZ-NLEAXPPASA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H26O2
Masa molowa310.4 g/mol
Nazwa IUPAC(9R,10R,13R,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,9,10,11,12,15,16-decahydrocyclopenta[a]phenanthren-3-one
InChIKeyPIGNQOCLJHWTGZ-NLEAXPPASA-N
SMILESCC[C@@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CCC3=C1CC[C@]2(C#C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 8(14)-Dehydro Norgestrel, 8(14)-Dehydro Norgestrel (>80%), (+/-)-(17alpha)-13-Ethyl-17-hydroxy-18,19-dinorpregna-4,8(14)-dien-20-yn-3-one
Powiązane formy tego związku
(9R,10R,13S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,9,10,11,12,15,16-decahydrocyclopenta[a]phenanthren-3-one C21H26O2
Izomery (ten sam wzór sumaryczny)
(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14-decahydrocyclopenta[a]phenanthren-3-one C21H26O2
4-[1-(4-hydroxyphenyl)-3,3,5-trimethylcyclohexyl]phenol C21H26O2
(1R,2R,4R,10R,11S,14S,16S,18S,19S)-10,14-dimethylhexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadec-5-ene-7,15-dione C21H26O2
(9S,10S,13R,17S)-17-acetyl-10,13-dimethyl-1,2,9,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one C21H26O2
(8R,9S,13S,14S,17R)-17-ethynyl-4,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol C21H26O2
(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,8,9,10,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one C21H26O2
(8S,10S,13S,14S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,12,14,15-octahydrocyclopenta[a]phenanthren-3-one C21H26O2
(8R,9S,13S,14S,17R)-17-ethynyl-2,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol C21H26O2
(8S,9S,13S,14S,17R)-17-ethynyl-4,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-1,17-diol C21H26O2
(8R,9S,10R,13S,14S,17R)-2,2,4,6,6,10-hexadeuterio-13-ethyl-17-ethynyl-17-hydroxy-7,8,9,11,12,14-hexahydro-1H-cyclopenta[a]phenanthren-3-one C21H26O2
(8S,13S,14S,17R)-17-hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one C21H26O2